Decravacitinib -(SOTYKU)- (Sep 2022)- to treat severe plaque sporiasis

Drug Name:
Decravacitinib -(SOTYKU)- (Sep 2022)- to treat severe plaque sporiasis

List Of Brands:

Indication Type Description:

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Pregnancy and lactation